Opus Genetics reported a quarterly loss of $0.75 per share, missing the Zacks Consensus Estimate of a $0.16 loss and widening from a $0.32 loss a year ago. The results indicate a materially weaker quarter versus expectations and prior-year performance, which could pressure the stock.
Opus Genetics reported a quarterly loss of $0.75 per share, missing the Zacks Consensus Estimate of a $0.16 loss and widening from a $0.32 loss a year ago. The results indicate a materially weaker quarter versus expectations and prior-year performance, which could pressure the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.58
Ticker Sentiment
